Please login to the form below

Not currently logged in
Email:
Password:

New member for Baxterís board of directors

Baxter International has elected Dr Wayne T Hockmeyer to serve as a member of its board of directors from September 2007

Baxter International has elected Dr Wayne T Hockmeyer to serve as a member of its board of directors from September 2007.

Hockmeyer founded MedImmune and served as its CEO and chairman from 1988 to 2000. MedImmune develops therapies for infectious disease, inflammatory disease and cancer and was recently acquired by AstraZeneca.

"Wayne is an exciting addition to our board of directors and we welcome the strong executive, scientific and operational experience he brings," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer. "His extensive scientific and R&D expertise will be invaluable in helping Baxter achieve its innovation and growth objectives."

Before Medimmune, Hockmeyer was vice-president of laboratory research and product development at Praxis Biologics and served as chief of the department of immunology at Walter Reed Army Institute of Research.

Hockmeyer is a member of the boards of directors of Middlebrook Pharmaceuticals, GenVec and Idenix Pharmaceuticals.

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics